by Truveta News | Feb 13, 2025 | News
Truveta Data has now expanded to include new commercial, Medicare, and Medicaid closed claims on more than 200 million patients, linked with electronic health record (EHR) data for more than 120 million patients already part of Truveta Data. Truveta Data now provides...
by Truveta News | Jan 13, 2025 | News
Today, leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence, and Trinity Health, announce the Truveta Genome Project, an innovative collaboration to generate genetic data on tens of millions of...
by Truveta News | Jan 9, 2025 | News
Truveta was named a gold winner in Most Innovative Company of the Year for medium-sized companies (100-999 employees) in the Best in Biz Awards 2024, the only independent business awards program judged by editors and reporters from North American publications. The...
by Truveta staff | Dec 6, 2024 | News
New results released this week from the SURMOUNT-5 clinical trial comparing tirzepatide (Zepbound) to semaglutide (Wegovy) are closely aligned to Truveta Research’s GLP-1 comparative effectiveness study, initially shared more than a year ago on November 27, 2023 and...
by Truveta News | Nov 20, 2024 | News
We are excited to share that our platform Truveta Studio and Truveta Data have earned certified status by HITRUST for information security. This achievement places Truveta in an elite group of organizations worldwide that have earned this certification. HITRUST r2...
